Download PDF
CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2024; 07(03): 118-128
DOI: 10.1055/s-0044-1788596
Review Article

Hypothyroidism in Older Adults: A Concise Review of the Recent Literature

Kamal Abouglila
1   Department of Endocrinology, County Durham and Darlington NHS Foundation Trust, Durham, United Kingdom
,
Syed Fahim Mukhtar
2   Department of Geriatric Medicine, University Hospital Lewisham, London, England, United Kingdom
,
Issam M. Hajjaji
3   Department of Medicine, Faculty of Medicine, University of Tripoli, Tripoli, Libya
,
Shehla Sheikh
4   KGN Diabetes & Endocrinology Centre, Mumbai, Maharashtra, India
,
Salem A. Beshyah 
5   Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
6   Department of Endocrinology, Yas Clinic Khalifa City, Abu Dhabi, United Arab Emirates
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction Hypothyroidism (HypoT) is a common condition whose prevalence varies according to regional and ethnic factors, dietary iodine, gender, and age. The symptoms of HypoT are generally nonspecific, with considerable overlap with other conditions. These symptoms are not useful for diagnosing HypoT, and a thyroid function test is required for a final diagnosis.

Materials and methods We aimed to provide an overview of the recent global literature on HypoT in older adults. A narrative, nonsystematic review of the international literature from a single major medical online database (PubMed) for the past 5 years was performed. The relevant literature was narrated in a concise thematic account.

Results Most studies and expert opinions reiterated the benefit of replacement therapy in younger and middle-aged individuals. A good volume of literature also considered the interplay between thyroid hormones and (1) cardiovascular function and risk factors, (2) cognitive function, (3) mental health, and (4) quality of life. Most workers are cognizant of the important difference in normal ranges of thyroid-stimulating hormone (TSH) and the consequent TSH targets in older adults compared to younger age groups. Extra care is recommended for the initiation and titration of thyroid hormone replacement therapy to avoid cardiovascular and skeletal adverse effects of relative overtreatment.

Conclusion While clinical benefit is evident in patients under age 65 with overt and subclinical HypoT who are treated with levothyroxine, treatment may be harmful in older adults with subclinical HypoT. The 97th percentile of TSH distribution is 7.5 mIU/L for patients over age 80. Hence, TSH goals should be individualized in older adults to achieve any possible benefit and avoid unnecessary harm.

Keywords

hypothyroidism - subclinical hypothyroidism - thyroid hormones - older adults - cardiovascular quality of life - cognitive function

Authors' Contributions

All authors reviewed the whole document for intellectual content. All authors approved its final version.


Disclaimer

To the best of our abilities, we presented our perception of the published work in good faith. Original authors cannot be held responsible for any misrepresentation.




Publication History

Article published online:
05 August 2024

© 2024. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet 2017; 390 (10101): 1550-1562
    CrossrefPubMedGoogle Scholar
  • 2 Chiovato L, Magri F, Carlé A. Hypothyroidism in context: where we've been and where we're going. Adv Ther 2019; 36 (Suppl. 02) 47-58
    CrossrefPubMedGoogle Scholar
  • 3 Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA 2019; 322 (02) 153-160
    CrossrefPubMedGoogle Scholar
  • 4 Chen Y, Tai HY. Levothyroxine in the treatment of overt or subclinical hypothyroidism: a systematic review and meta-analysis. Endocr J 2020; 67 (07) 719-732
    CrossrefPubMedGoogle Scholar
  • 5 Alzahrani AS, Al Mourad M, Hafez K. et al. Diagnosis and management of hypothyroidism in Gulf Cooperation Council (GCC) countries. Adv Ther 2020; 37 (07) 3097-3111
    CrossrefPubMedGoogle Scholar
  • 6 Mammen JSR. Thyroid and aging. Endocrinol Metab Clin North Am 2023; 52 (02) 229-243
    CrossrefPubMedGoogle Scholar
  • 7 Duntas LH, Yen PM. Diagnosis and treatment of hypothyroidism in the elderly. Endocrine 2019; 66 (01) 63-69
    CrossrefPubMedGoogle Scholar
  • 8 Effraimidis G, Watt T, Feldt-Rasmussen U. Levothyroxine therapy in elderly patients with hypothyroidism. Front Endocrinol (Lausanne) 2021; 12: 641560
    CrossrefPubMedGoogle Scholar
  • 9 Perkins JM, Papaleontiou M. Towards de-implementation of low-value thyroid care in older adults. Curr Opin Endocrinol Diabetes Obes 2022; 29 (05) 483-491
    CrossrefPubMedGoogle Scholar
  • 10 Biondi B, Cappola AR. Subclinical hypothyroidism in older individuals. Lancet Diabetes Endocrinol 2022; 10 (02) 129-141
    CrossrefPubMedGoogle Scholar
  • 11 van der Spoel E, van Vliet NA, Poortvliet RKE. et al. Incidence and determinants of spontaneous normalization of subclinical hypothyroidism in older adults. J Clin Endocrinol Metab 2024; 109 (03) e1167-e1174
    CrossrefPubMedGoogle Scholar
  • 12 Calissendorff J, Falhammar H. To treat or not to treat subclinical hypothyroidism, what is the evidence?. Medicina (Kaunas) 2020; 56 (01) 40
    CrossrefPubMedGoogle Scholar
  • 13 Ross DS. Treating hypothyroidism is not always easy: when to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapy. J Intern Med 2022; 291 (02) 128-140
    CrossrefPubMedGoogle Scholar
  • 14 Zhao C, Wang Y, Xiao L, Li L. Effect of levothyroxine on older patients with subclinical hypothyroidism: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 2022; 13: 913749
    CrossrefPubMedGoogle Scholar
  • 15 Sgarbi JA, Ward LS. A practical contemporary approach to decision-making on subclinical hypothyroidism. Arch Endocrinol Metab 2021; 65 (01) 32-39
    PubMedGoogle Scholar
  • 16 Duntas LH, Jonklaas J. Levothyroxine dose adjustment to optimise therapy throughout a patient's lifetime. Adv Ther 2019; 36 (Suppl. 02) 30-46
    CrossrefPubMedGoogle Scholar
  • 17 de Montmollin M, Feller M, Beglinger S. et al. L-thyroxine therapy for older adults with subclinical hypothyroidism and hypothyroid symptoms: secondary analysis of a randomized trial. Ann Intern Med 2020; 172 (11) 709-716
    CrossrefPubMedGoogle Scholar
  • 18 Gottwald-Hostalek U, Razvi S. Getting the levothyroxine (LT4) dose right for adults with hypothyroidism: opportunities and challenges in the use of modern LT4 preparations. Curr Med Res Opin 2022; 38 (11) 1865-1870
    CrossrefPubMedGoogle Scholar
  • 19 Brun VH, Eriksen AH, Selseth R. et al. Patient-tailored levothyroxine dosage with pharmacokinetic/pharmacodynamic modeling: a novel approach after total thyroidectomy. Thyroid 2021; 31 (09) 1297-1304
    CrossrefPubMedGoogle Scholar
  • 20 Paschou SA, Bletsa E, Stampouloglou PK. et al. Thyroid disorders and cardiovascular manifestations: an update. Endocrine 2022; 75 (03) 672-683
    CrossrefPubMedGoogle Scholar
  • 21 Huang M, Yang S, Ge G, Zhi H, Wang L. Effects of thyroid dysfunction and the thyroid-stimulating hormone levels on the risk of atrial fibrillation: a systematic review and dose-response meta-analysis from cohort studies. Endocr Pract 2022; 28 (08) 822-831
    CrossrefPubMedGoogle Scholar
  • 22 Delitala AP, Scuteri A, Maioli M, Mangatia P, Vilardi L, Erre GL. Subclinical hypothyroidism and cardiovascular risk factors. Minerva Med 2019; 110 (06) 530-545
    PubMedGoogle Scholar
  • 23 Ettleson MD. Cardiovascular outcomes in subclinical thyroid disease: an update. Curr Opin Endocrinol Diabetes Obes 2023; 30 (05) 218-224
    CrossrefPubMedGoogle Scholar
  • 24 Chrysant SG. The current debate over treatment of subclinical hypothyroidism to prevent cardiovascular complications. Int J Clin Pract 2020; 74 (07) e13499
    CrossrefPubMedGoogle Scholar
  • 25 Gluvic ZM, Zafirovic SS, Obradovic MM, Sudar-Milovanovic EM, Rizzo M, Isenovic ER. Hypothyroidism and risk of cardiovascular disease. Curr Pharm Des 2022; 28 (25) 2065-2072
    CrossrefPubMedGoogle Scholar
  • 26 Gencer B, Moutzouri E, Blum MR. et al. The impact of levothyroxine on cardiac function in older adults with mild subclinical hypothyroidism: a randomized clinical trial. Am J Med 2020; 133 (07) 848-856.e5
    CrossrefPubMedGoogle Scholar
  • 27 Chahine J, Ala CK, Gentry JL, Pantalone KM, Klein AL. Pericardial diseases in patients with hypothyroidism. Heart 2019; 105 (13) 1027-1033
    CrossrefPubMedGoogle Scholar
  • 28 Büchi AE, Feller M, Netzer S. et al. Bone geometry in older adults with subclinical hypothyroidism upon levothyroxine therapy: a nested study within a randomized placebo controlled trial. Bone 2022; 161: 116404
    CrossrefPubMedGoogle Scholar
  • 29 Gonzalez Rodriguez E, Stuber M, Del Giovane C. et al. Skeletal effects of levothyroxine for subclinical hypothyroidism in older adults: a TRUST randomized trial nested study. J Clin Endocrinol Metab 2020; 105 (01) dgz058
    CrossrefPubMedGoogle Scholar
  • 30 Netzer S, Chocano-Bedoya P, Feller M. et al. The effect of thyroid hormone therapy on muscle function, strength and mass in older adults with subclinical hypothyroidism-an ancillary study within two randomized placebo controlled trials. Age Ageing 2023; 52 (01) afac326
    CrossrefPubMedGoogle Scholar
  • 31 Du FM, Kuang HY, Duan BH, Liu DN, Yu XY. Effects of thyroid hormone and depression on common components of central obesity. J Int Med Res 2019; 47 (07) 3040-3049
    CrossrefPubMedGoogle Scholar
  • 32 Moon N, Aryan M, Westerveld D, Nathoo S, Glover S, Kamel AY. Clinical manifestations of copper deficiency: a case report and review of the literature. Nutr Clin Pract 2021; 36 (05) 1080-1085
    CrossrefPubMedGoogle Scholar
  • 33 Wildisen L, Feller M, Del Giovane C. et al. Effect of levothyroxine therapy on the development of depressive symptoms in older adults with subclinical hypothyroidism: an ancillary study of a randomized clinical trial. JAMA Netw Open 2021; 4 (02) e2036645
    CrossrefPubMedGoogle Scholar
  • 34 Stuber MJ, Moutzouri E, Feller M. et al. Effect of thyroid hormone therapy on fatigability in older adults with subclinical hypothyroidism: a nested study within a randomized placebo-controlled trial. J Gerontol A Biol Sci Med Sci 2020; 75 (09) e89-e94
    CrossrefPubMedGoogle Scholar
  • 35 Danicic JM, Inder WJ, Kotowicz MA. Impact of subclinical hypothyroidism on health-related quality of life: a narrative review. Intern Med J 2021; 51 (09) 1380-1387
    CrossrefPubMedGoogle Scholar
  • 36 Eslami-Amirabadi M, Sajjadi SA. The relation between thyroid dysregulation and impaired cognition/behaviour: an integrative review. J Neuroendocrinol 2021; 33 (03) e12948
    CrossrefPubMedGoogle Scholar
  • 37 Zhong J, Mu D, Zou Y, Li L, Cheng X, Qiu L. High thyrotropin levels and risk of mortality in the elderly with subclinical hypothyroidism: a systematic review and meta-analysis. Endocr Pract 2023; 29 (03) 206-213
    CrossrefPubMedGoogle Scholar
  • 38 Tsai TY, Tu YK, Munir KM. et al. Association of hypothyroidism and mortality in the elderly population: a systematic review and meta-analysis. J Clin Endocrinol Metab 2020; 105 (06) dgz186
    PubMedGoogle Scholar
  • 39 van Heemst D. The ageing thyroid: implications for longevity and patient care. Nat Rev Endocrinol 2024; 20 (01) 5-15
    CrossrefPubMedGoogle Scholar
  • 40 Du Puy RS, Poortvliet RKE, Mooijaart SP. et al. Outcomes of thyroid dysfunction in people aged eighty years and older: an individual patient data meta-analysis of four prospective studies (Towards Understanding Longitudinal International Older People Studies Consortium). Thyroid 2021; 31 (04) 552-562
    CrossrefPubMedGoogle Scholar
  • 41 Peng CC, Huang HK, Wu BB, Chang RH, Tu YK, Munir KM. Association of thyroid hormone therapy with mortality in subclinical hypothyroidism: a systematic review and meta-analysis. J Clin Endocrinol Metab 2021; 106 (01) 292-303
    CrossrefPubMedGoogle Scholar
  • 42 Gottwald-Hostalek U, Schulte B. Low awareness and under-diagnosis of hypothyroidism. Curr Med Res Opin 2022; 38 (01) 59-64
    CrossrefPubMedGoogle Scholar
  • 43 Beshyah SA, Bashir M, Hafidh K. et al. Impact of patient age on management of hypothyroidism: a survey of physicians from three developing regions. J Diab Endocr Pract, In press
    Google Scholar